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SDSThe stability of bacteriorhodopsin (bR) has often been assessed using SDS unfolding assays that monitor the
transition of folded bR (bRf) to unfolded (bRu). While many criteria suggest that the unfolding curves reﬂect
thermodynamic stability, slow retinal (RET) hydrolysis during refolding makes it impossible to perform the
most rigorous test for equilibrium, i.e., superimposable unfolding and refolding curves. Here we made a
new equilibrium test by asking whether the refolding rate in the transition zone is faster than RET hydrolysis.
We ﬁnd that under conditions we have used previously, refolding is in fact slower than hydrolysis, strongly
suggesting that equilibrium is not achieved. Instead, the apparent free energy values reported previously are
dominated by unfolding rates. To assess how different the true equilibrium values are, we employed an alter-
native method by measuring the transition of bRf to unfolded bacterioopsin (bOu), the RET-free form of un-
folded protein. The bRf-to-bOu transition is fully reversible, particular when we add excess RET. We compared
the difference in unfolding free energies for 13 bR mutants measured by both assays. For 12 of the 13 mutants
with a wide range of stabilities, the results are essentially the same within experimental error. The congru-
ence of the results is fortuitous and suggests the energetic effects of most mutations may be focused on
the folded state. The bRf-to-bOu reaction is inconvenient because many days are required to reach equilibri-
um, but it is the preferable measure of thermodynamic stability. This article is part of a Special Issue entitled:
Protein Folding in Membranes.n Folding in Membranes.
1 310 206 4749.
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Measuring protein stability requires a method to drive the folding
equilibrium in favor of the unfolded state. For water-soluble proteins
this is typically accomplished using urea, Gdn∙HCl or temperature. To
our knowledge, thermal unfolding has not been found to be reversible
for any helical membrane proteins [1–6]. Urea and Gdn∙HCl have been
particularly effective for beta-barrel membrane proteins [7] and have
been found to reversibly unfold a few large helical membrane proteins
[7,8]. An alternative to urea andGdn∙HCl is to use a denaturing detergent
[9,10]. SDS has the advantage that the protein is maintained in a micelle
environment, which leads to maintenance of considerable secondary
structure and may therefore be a better mimic of the more structured
unfolded state in a bilayer [9,11–14].
Bacteriorhodopsin can be completely refolded from an SDS unfolded
state [11,15,16]. Titration of bR with SDS from a DMPC/CHAPSO or
DMPC/CHAPS solution, leads to bRf-to-bRu unfolding curves that arereasonably stable over the course of an hour (see below). Moreover, ki-
netic constants in DMPC/CHAPS conditions indicate that unfolding to
bRu should reach equilibrium in a matter of minutes [17–19]. The
unfolding curves are also well modeled by a two-state equilibrium
and the extrapolated kinetic constants of the unfolding and refolding
reactions are consistent with extracted equilibrium constants within
the transition zones [17,18]. Thus, we have assumed that the unfolding
transitions reﬂect a folding equilibrium, in spite of the fact that themost
rigorous test of equilibrium is not possible, i.e., overlap of the unfolding
and refolding curves. We have now come to the conclusion, however,
that true equilibrium cannot be achieved under the DMPC/CHAPSO
conditions we have used in the past (16 mM DMPC, 6 mM CHAPSO)
[20–25], because RET hydrolysis exceeds the rate of refolding near the
midpoint of the observed unfolding transition (see below).
Instead of measuring the bRf-to-bRu transition that is accessed
from unfolding at short time scales, it is also possible to measure
the bRf-to-bOu transition if the reaction is allowed to proceed for
many days. The advantage of the bRf-to-bOu transition is that it can
be rigorously shown that the reaction is at equilibrium in the transi-
tion zones because the folding and unfolding curves are essentially
the same [26]. To measure the error associated with the equilibrium
1050 Z. Cao et al. / Biochimica et Biophysica Acta 1818 (2012) 1049–1054assumption for the bRf-to-bRu transition, we compared the effects of
mutations on both reactions. Fortuitously, the results are remarkably
similar for both measurements.
2. Materials and methods
2.1. Materials
All bR variants were prepared as described [20,27,28]. 1,2-Dimyr-
istoyl-sn-glycerol-3-phosphocholine (DMPC) was purchased
from Avanti Polar Lipids. 3((3-cholamidopropyl)dimethylammo-
nio)-2-hydroxy-1-propanesulphonate (CHAPSO) was purchased
from Anatrace. Sodium dodecyl sulfate (SDS) and all-trans retinal
(RET) were purchased from Sigma-Aldrich.
2.2. Methods
2.2.1. bRf-to-bRu unfolding and bRu-to-bRf refolding assays
The bRf-to-bRu unfolding assays were performed as described
by Faham S. et al. [20]. Purplemembranewas dissolved in a 2500 μL solu-
tion containing 15 mM DMPC, 6 mM CHAPSO and 10 mM sodium phos-
phate [pH 6.3]. The ﬁnal concentration of the bR protein was in a range
of 3–7 μM. After equilibration in dark for 1 h, the solution was titrated
by using an SDS titrant at room temperature in a 1-cm cuvette stirred
with a magnetic stir bar. The SDS titrant contained 20% (w/v) SDS,
15 mM DMPC, 6 mM CHAPSO and 10 mM sodium phosphate [pH 6.3].
10 μL of the SDS titrant was added every 3 min during the titration.
To test the effect of RET hydrolysis on the time evolution of the
bRf-to-bRu unfolding curve, a series of 200 μL solutions containing
3.7 μM wild-type bR, 15 mM DMPC, 6 mM CHAPSO, 10 mM sodium
phosphate [pH 6.3] and different amounts of SDS varying from 5 to
71 mM were made at the same time and then loaded on a 96-well
micro-plate (Thermo Scientiﬁc). The absorbance of each solution at
560 nm was monitored using a SpectraMax M5 plate reader (Molec-
ular Devices).
To examine the bRu-to-bRf refolding reactions, purple membrane
was dissolved to make a ﬁnal solution containing 37 μM bR, 15 mM
DMPC, 6 mM CHAPSO, 10 mM sodium phosphate [pH 6.3] and
66.5 mM SDS. 3 min later, the absorbance at 560 nm disappeared
and absorbance at 440 nm reached the maximal value. 20 μL of the
unfolded bR solution was then mixed with a series of 180 μL solu-
tions. The ﬁnal solutions contained 3.7 μM wild-type bR, 15 mM
DMPC, 6 mM CHAPSO, 10 mM sodium phosphate [pH 6.3] and differ-
ent amounts of SDS varying from 5.2 to 66.5 mM.
2.2.2. bRf-to-bOu unfolding and bOu-to-bRf refolding assays
The bRf-to-bOu unfolding and bOu-to-bRf refolding assays were
performed similarly to Chen and Gouaux [26]. The main difference
from their experiments was that we equilibrated each sample for
much longer times.
For the unfolding assays, a stock solutionwas prepared by dissolving
purple membrane in a stock solution containing 20.625 mM DMPC,
22 mM CHAPSO and 13.75 mM sodium phosphate [pH 6.3]. For experi-
ments with added RET, 15.4 μM all-trans RET was included in the stock
solution. 160 μL aliquots of the stock solutionwere combinedwith 60 μL
SDS solutions at various concentrations. The ﬁnal solutions contained
1.5–3 μMbR, 15 mMDMPC, 16 mMCHAPSO, 10 mMsodiumphosphate
[pH 6.3], 0 or 11.2 μM all-trans RET and SDS varying from 8 to 138 mM.
For the refolding assays, bR was ﬁrst unfolded in a buffer containing
15 mM DMPC, 16 mM CHAPSO, 10mM sodium phosphate [pH 6.3] and
104 mM SDS. After equilibration for 1 h in dark, the absorbance at
560 nmdisappeared and the absorbance at 390 nm reached themaximal
value. Then, the unfolded bR solution was mixed with a series of DMPC/
CHAPSO/SDS/RET/sodium phosphate [pH 6.3] solutions with varying
SDS concentrations. The ﬁnal solutions contained 1.5–3 μM bR, 15 mM
DMPC, 16 mM CHAPSO, 10 mM sodium phosphate [pH 6.3], 0 or11.2 μM all-trans RET and different amounts of SDS varying from 13 to
79 mM.
After the samples for unfolding and refolding assays were pre-
pared, all the samples without added RET were equilibrated in dark
at room temperature for 212 h (~9 days) and those with added RET
were equilibrated in dark at room temperature for 96 h (~4 days).
200 μL of each unfolding and refolding sample was loaded on a 96-
well UV-star micro-plate (Greiner Bio-One). Absorbance at 560 nm
and ﬂuorescence emission at 335 nm (excitation at 290 nm) of each
solution were measured by SpectraMax M5 plate reader (Molecular
Devices).
For unfolding experiments without added RET, the unfolding curves
can be described by
Abs560 ¼ Abso560⋅Ff ; ð1Þ
where Abs560o is the absorbance of the subdenaturant line and its ex-
tension over the experimental XSDS range, which represents the theo-
retical absorbance if all the bR is folded and is assumed to be linearly
dependent on XSDS:
Abso560 ¼ aXSDS þ b; ð2Þ
and Ff is the fraction of the folded state in each bR variant, i.e. Ff=
[bRf]/c, where c is the total concentration of each bR variant in units
of μM. Since the unfolding free energy calculated for a standard
state of 1 μM is deﬁned as
ΔGU ¼ −RT ln bOu½ ⋅ RET½ = bRf½ ð Þ ¼ −RT ln c 1−Ffð Þ2=Ff
h i
;
where RT is 0.592 kcal mol−1, Ff can be written as a function of ΔGU
and c:
Ff ¼
2þ exp−ΔGU= RTð Þ½ c −
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
exp−2ΔGU= RTð Þ½ 
c2
þ 4exp−ΔGU= RTð Þ½ c
q
2
: ð3Þ
We assumed that ΔGU has a linear relationship with XSDS:
ΔGU ¼ m XSDS–Cmð Þ–RT ln 0:5cð Þ:
Then Eq. (3) can be re-written as
Ff ¼
2þ exp− m⋅ XSDS−Cmð Þþ ln2½ RT −
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
exp−2⋅ m⋅ XSDS−Cmð Þþ ln2½ RT þ 4⋅ exp− m⋅ XSDS−Cmð Þþ ln2½ RT
q
2
: ð4Þ
By plugging Eqs. (2) and (4) into Eq. (1), we derived the equation
of Abs560 in the expression of XSDS and used this equation to ﬁt each
unfolding curve without added RET:
Abs560 ¼ aXSDS þ bð Þ⋅
2þ exp− m⋅ XSDS−Cmð Þþ ln2½ RT −
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
exp−2⋅ m⋅ XSDS−Cmð Þþ ln2½ RT þ 4⋅ exp− m⋅ XSDS−Cmð Þþ ln2½ RT
q
2
:
ð5Þ
Parameters a, b, m and Cm were ﬁt using Kaleighdagraph 4.1. The
unfolding free energies for wild-type and mutant were compared by
subtracting ΔGUWT from ΔGUmutant at the midpoint of the wild-type
transition, XSDS=CmWT=0.572.
For unfolding experiments with added RET, the RET concentration
was held constant, so the RET concentration was combined with
the equilibrium constant, giving the unfolding reaction a pseudo 1:1
stoichiometry, i.e. ΔGU=− RT ln([bOu]/[bRf])=− RT ln[(1–Ff)/Ff]).
Fig. 1. Effect of RET hydrolysis on the SDS-induced unfolding of wild-type bR. (a)
Change of the wild-type bRf-to-bRu unfolding curve in time. (b) Plot of normalized ab-
sorbance at 560 nm against the SDS mole fraction concentration, XSDS, for the wild-type
bRf-to-bRu unfolding and bRu-to-bRf refolding experiments. (c) Change of absorbances
at 390, 440 and 560 nm in time when the wild-type protein was refolded from bRu at
the apparent Cm of the bRf-to-bRu transition (XSDS=0.673).
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Ff ¼
1
1þ exp−ΔGU= RTð Þ½ 
: ð6Þ
We assume that ΔGU has a linear relationship with XSDS:
ΔGU ¼ m XSDS–Cmð Þ:
Then Ff can be re-written as
Ff ¼
1
1þ exp−m⋅ XSDS−Cmð Þ= RTð Þ½ 
: ð7Þ
By plugging Eqs. (2) and (7) into Eq. (1), we obtained the equation
of Abs560 in terms of XSDS and used this equation to ﬁt each unfolding
curve with added RET:
Abs560 ¼
a⋅XSDS þ b
1þ exp−m⋅ XSDS−Cmð Þ= RTð Þ½ 
:
Parameters a, b, m and Cm were ﬁt using Kaleighdagraph 4.1. The
unfolding free energies for wild-type and mutant were compared by
subtracting ΔGUWT from ΔGUmutant at the midpoint of the wild-type
transition, XSDS=CmWT=0.611.
3. Results
The bRf-to-bRu reaction is complicated by the slow hydrolysis of
RET, which occurs from the fully unfolded protein with a half life of
around 12 min [17]. Because loss of RET is slow until there is a signif-
icant fraction of unfolded protein, the unfolding curves are relatively
stable over a modest time scale. Fig. 1a shows the change in unfolding
curves over time. Minimal change is seen over the ﬁrst 30 min. These
results, combined with measurements of unfolding rates under simi-
lar conditions [17,18], which indicate that unfolding should be
achieved in a matter of minutes, suggest that the bRf-to-bRu unfolding
curves can be used to extract equilibrium constants over a useable
time scale. Nevertheless, due to RET hydrolysis during refolding, the
refolding curves do not superimpose with the unfolding curves
(Fig. 1b). At low XSDS, where refolding is rapid, the protein refolds
to near completion, but in the transition zones where refolding is
slow, RET hydrolysis becomes a signiﬁcant factor, complicating the
interpretation.
We therefore sought a further test of the equilibrium assumption.
A simpliﬁed reaction scheme for unfolding followed by essentially ir-
reversible RET hydrolysis is given by:
bRf ⇄
ku
kf
bRu→
khyd
bOu þ RET
Where ku is the unfolding rate constant, kf is the refolding rate
constant and khyd is the RET hydrolysis rate constant. For equilibrium
between bRf and bRu to be achieved, kf must be greater than khyd. To
test whether this is true in the transition zone, we rapidly unfolded
the protein to bRu at a high SDS concentration (XSDS=0.78), then
jumped back an SDS concentration at the midpoint of the observed
transition (XSDS=0.67) and monitored both refolding at 560 nm
and hydrolysis at 390 nm. As shown in Fig. 1c, we essentially saw
no refolding before hydrolysis was complete. Thus, under the solution
conditions we have used for measuring stability, equilibrium cannot
be established near the midpoint of the transition and the extent of
the observed unfolding must be limited by the unfolding rate.
We therefore measured the unfolding free energy differences for a
variety of mutants using an alternative thermodynamic stabilitymeasurement. If the unfolding reactions are left to incubate, a bRf-
to-bOu equilibrium is attained as described by Chen and Gouaux
[26]: bRf↔ bOu+RET. In our hands it took 9 days to reach equilibri-
um at room temperature as judged by the nearly superimposable
folding and unfolding curves monitored by absorbance at 560 nm
and ﬂuorescence at 335 nm (Fig. 2a and b). By adding excess RET in
the samples, we shortened the equilibration time to 4 days and the
folding and unfolding curves monitored by absorbance at 560 nm
and ﬂuorescence at 335 nm (Fig. 2c and d) were more superimpos-
able. The SDS concentration at the midpoint of the transition zone,
Cm, was much higher for the bRf-to-bRu reaction [17,18] than for the
bRf-to-bOu reaction, which is consistent with the spontaneous hydro-
lysis of the RET Schiff base in SDS solutions at neutral pH [29]. In ad-
dition, the only peaks observed in the absorbance spectra throughout
the transition were at 560 nm, corresponding to bRf, and at 390 nm,
corresponding to free RET (Fig. 3). No indications of a contribution
from bRu at 440 nm were evident, which indicates that the product
of the unfolding experiment was bO and free RET but not bRu
[15,17,26]. The unfolding curves derived from Abs560 and Flu335
were essentially the same (Fig. 4), and the absorbance spectra exhib-
ited an isosbestic point (Fig. 3), suggesting that the unfolding of bRf to
bOu can be described by a two-state model. As the bRf-to-bOu reaction
Fig. 2. Equilibrium unfolding (bRf-to-bOu) and refolding (bOu-to-bRf) of wild-type protein. (a) The unfolding and refolding samples without added RET monitored by absorbance at
560 nm after incubated for ~9 days. (b) The unfolding and refolding samples without added RET monitored by ﬂuorescence at 335 nm after incubated for ~9 days. (c) The unfolding
and refolding samples with added RET monitored by absorbance at 560 nm after incubated for ~4 days. (d) The unfolding and refolding samples with added RET monitored by ﬂuo-
rescence at 335 nm after incubation for ~4 days.
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drive the equilibrium to higher SDS concentrations. Indeed, this is
what we observed (Fig. 4), and is consistent with a thermodynamic
equilibrium process. The addition of free RET has two advantages:
(1) the concentration of RET becomes a constant, simplifying analysis
of the unfolding curves and (2) the time it took to reach equilibrium
decreases from 9 days to 4 days.
The ΔΔGU values obtained using the bRf-to-bOu transition and
ΔΔGUapp values using the bRf-to-bRu transition were measured for 13
mutants and are listed in Table 1. We compare measurements at the
center of the transition zones for the wild-type protein to minimize
extrapolations outside of the observable range of fraction unfolded
(XSDS=0.572 for the bRf-to-bOu transition without added RET,
XSDS=0.611 for the bRf-to-bOu transition in the presence of 11.2 μM
RET, and XSDS=0.673 for the bRf-to-bRu transition). For 12 of the 13
mutants, the ΔΔGUapp and ΔΔGU values measured using the two tran-
sitions bRf-to-bRu and bRf-to-bOu, respectively, were generally within
the experimental error. The correlation between the differentFig. 3. Absorbance spectra of the wild-type protein as a function of SDS concentration.
The spectra were taken at XSDS=0.315, 0.572 and 0.734, where the protein was
completely folded, 50% unfolded and completely unfolded, respectively.measures of ΔΔGU for the 12 mutants is shown in Fig. 5, illustrating
the close correspondence between the twomethods. An ideal correla-
tion would have an intercept at 0 kcal mol−1 and a slope of 1.0. For
the ﬁtted line, the intercept is (−0.12±0.09) kcal mol−1 and the
slope is 1.08±0.06.
4. Discussion
While the bRf-to-bRu unfolding transition apparently reaches a
steady state rapidly, RET hydrolysis and slow refolding preclude es-
tablishment of a true equilibrium under the conditions we have
used. In contrast, the bRf-to-bOu equilibrium is stable. Nevertheless,
when we compare the effects of 12 of the 13 mutations on the two re-
actions, very similar results are obtained for most mutations. The or-
igin of the fortuitous congruence of the two measures is unclear. One
possibility is that mutations largely alter ku, but not kf. This couldFig. 4. Wild-type bRf-to-bOu unfolding curve. Plot of the fraction of the native-state
protein, Fn, derived by monitoring absorbance and ﬂuorescence for the reactions with-
out and with added RET. Superposition of the curves is consistent with a two-state
model for SDS-induced unfolding of bRf to bOu. The transition shifts to higher SDS con-
centration in the presence of added RET, consistent with an equilibrium reaction that
releases RET. Under both conditions with and without added RET, 3 μM of wild-type
protein was included in the samples.
Table 1
ΔΔGU of bR variants tested from the bRf-to-bOu and bRf-to-bRu reactions at certain XSDS.
Single mutants ΔΔGUa (bRf-to-bOu without added RET) ΔΔGUa (bRf-to-bOu with 11.2 μM RET) ΔΔGUa (bRf-to-bRu)
XSDS 0.572b 0.611b 0.572 0.611 0.673b
K41A – −1.2±0.3 −1.4±0.3 −1.4±0.3 −1.4±0.2
F42A −2.6±0.5 −2.2±0.3 −2.1±0.3 −2.1±0.2 −2.0±0.2
Y43A −1.9±0.3 −2.1±0.3 −1.9±0.4 −1.9±0.3 −1.6±0.2
I45A −2.2±0.4 −2.1±0.2 −2.1±0.3 −2.1±0.3 −1.9±0.3
T46A – −2.8±0.3 −2.3±0.3 −2.3±0.3 −2.2±0.3
T47A −1.1±0.3 −0.9±0.2 −1.6±0.3 −1.4±0.2 −1.1±0.2
V49A −0.3±0.4 −0.3±0.3 −0.7±0.2 −0.6±0.2 −0.3±0.2
I52A −2.0±0.3 −1.6±0.2 −2.0±0.2 −1.9±0.2 −1.5±0.1
F54A – −0.9±0.3 −0.5±0.2 −0.4±0.2 −0.4±0.1
M56A – 1.6±0.3 2.0±0.2 1.9±0.2 1.6±0.1
S59A – −0.1±0.2 −0.1±0.2 −0.1±0.2 −0.1±0.1
M60A – −1.3±0.3 −1.1±0.3 −1.1±0.3 −1.0±0.2
P50A −1.1±0.3 −1.0±0.2 0.7±0.4 0.7±0.3 0.6±0.1
a Unit of ΔΔGU: kcal mol−1.
b Cm of the wild-type bR for each reaction.
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native state, but minimal effects on the transition state or unfolded
state free energies. The effects of one mutant, P50A, were very differ-
ent when measured by the two methods. It was found to be signiﬁ-
cantly stabilizing in the bRf-to-bRu transition, but destabilizing in
the bRf-to-bOu transition. P50 is in the center of a kinked helix in
the folded bR structure, so it is perhaps not surprising that there
might be long-range effects imparted by this mutation that differen-
tially alter unfolding transition state.
Booth and co-workers have found excellent correspondence between
equilibrium and kinetic measurements [17,18]. Their conditions are
slightly different than the ones we have used, however, employing
CHAPS instead of CHAPSO and the CHAPS is used at a higher concentra-
tion. We have observed that increasing CHAPSO concentrations from 6
to 16 mM increases refolding rates (unpublished result), which could
then lead to equilibrium for the bRf-to-bRu transition. Nevertheless, theFig. 5. Correlation between ΔΔGUapp values measured for the bRf-to-bRu transition
and the ΔΔGU values measured for the bRf-to-bOu transition. Square symbols refer to
values measured without added RET and circle symbols refer to values measured with
added RET. The open symbols refer to values for the P50Amutation, which is an outlier.
The least squares ﬁt line through all the ﬁlled symbols has a slope of 1.08±0.06 and
an intercept of−0.12±0.09 kcal mol−1. The correlation coefﬁcient is 0.97.bRf-to-bOu transition is the more reliable way to measure the effects of
mutations on thermodynamic stability.
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